Manager, HR Operations & Onboarding at Dyno Therapeutics

Waltham, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

BiotechnologyIndustries

Requirements

Bachelor’s degree in Human Resources, Business Administration, or a related field
5+ years of HR operations experience, preferably within biotech, pharmaceutical, or high-growth life sciences environments
Hands-on experience with ADP Workforce Now and Greenhouse ATS preferred
Experience designing and managing onboarding programs that provide a seamless introduction to Dyne’s culture and mission
Strong analytical and problem-solving skills with attention to detail and data accuracy
Excellent communication and organizational skills, with the ability to manage multiple priorities

Responsibilities

Support day-to-day HR operations, ensuring accuracy, efficiency, and compliance across onboarding, HRIS management, and benefits administration
Oversee and optimize workflows within ADP Workforce Now and Greenhouse ATS, ensuring seamless data flow and system integration
Design, manage, and continuously improve Dyne’s onboarding processes, systems, and programs to deliver an engaging and consistent new hire experience aligned with Dyne’s culture and values
Serve as the first point of contact for general HR inquiries, providing timely and accurate support to employees and managers
Ensure compliance with all employment-related documentation and recordkeeping requirements
Collaborate closely with Talent Acquisition, IT, and HR Business Partners to streamline processes and enhance service delivery
Partner with external vendors to manage Service Level Agreements and ensure high-quality service delivery
Oversee contract lifecycle and purchase order management, including creation, tracking, and reconciliation, ensuring alignment with procurement policies and timely vendor invoicing and payment processing
Identify, recommend, and implement automation or process improvements that enhance operational efficiency and employee experience
Support HR policy development, ensuring alignment with Dyne’s culture and compliance with applicable laws and regulations
Generate, analyze, and maintain accurate HR reports and dashboards by extracting data from HRIS and other systems to support strategic decision-making, compliance, and operational efficiency
Own the data submission of compensation benchmarking reports
Assist with immigration-related requests, documentation, and processes
Assist with benefits administration

Skills

ADP Workforce Now

Greenhouse ATS

HRIS Administration

Onboarding

Benefits Administration

HR Operations

Process Optimization

Workflow Management

Data Integrity

System Integration

Dyno Therapeutics

Develops AI-optimized gene therapy vectors

About Dyno Therapeutics

Dyno Therapeutics focuses on advancing gene therapy by utilizing Artificial Intelligence to create Adeno-associated virus (AAV) vectors. These vectors are essential tools for delivering genetic material into cells, which is crucial for effective gene therapy. The company's AI technology enables the design and optimization of these vectors, potentially enhancing the success of gene therapies. Dyno collaborates with major pharmaceutical and biotech companies, such as Astellas, Roche, Sarepta, and Novartis, to develop therapies for various diseases affecting the skeletal and cardiac muscles, central nervous system, liver, and eyes. Unlike many competitors, Dyno's unique approach leverages AI to improve the performance of AAV vectors, setting it apart in the biotech field. The company's goal is to improve gene therapy outcomes through its advanced vector technology, ultimately benefiting patients with serious health conditions.

Watertown, MassachusettsHeadquarters

2018Year Founded

$106MTotal Funding

SERIES_ACompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Remote Work Options

Risks

Gene therapy investment slowdown may impact Dyno's growth and innovation.

Manufacturing bottlenecks could hinder scaling of Dyno's operations.

Increased competition from companies like Form Bio challenges Dyno's market position.

Differentiation

Dyno uses AI to design optimized AAV vectors for gene therapy.

Their AI-driven CapsidMap platform enhances AAV vector development for muscle gene therapies.

Partnerships with major pharma companies like Astellas and Roche boost Dyno's market presence.

Upsides

AI-driven capsid design improves delivery efficiency and reduces manufacturing costs.

Collaboration with NVIDIA enhances biological sequence design for gene therapies.

Generative AI increases efficiency of eye and brain-targeted capsid delivery significantly.

Land your dream remote job 3x faster with AI

Try Jobo Free